AnalystsRyan Deschner
Ryan Deschner's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 25%
#1234 out of 4922 analysts
Average Return
+32.89%
Win Rate
58%7 out of 12
Risk vs Reward
Poor
Good

Ryan Deschner's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inozyme Pharma IncINZY
+269.44%$1.08$3.99
2025-03-11 -
2025-06-27
Buy
Trevi Therapeutics IncTRVI
+77.85%$3.16$5.62
2024-08-29 -
2025-06-27
Buy
Ars Pharmaceuticals IncSPRY
+62.65%$11.19$18.20
2024-07-24 -
2025-06-27
Buy
Ars Pharmaceuticals IncSPRY
+60.21%$11.36$18.20
2025-01-13 -
2025-06-27
Strong Buy
Ars Pharmaceuticals IncSPRY
+39.36%$13.06$18.20
2024-08-12 -
2025-06-27
Strong Buy

Ryan Deschner Analyst Color

Get additional color on Ryan Deschner's coverage of popular stocks

Ryan Deschner's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Inozyme Pharma IncINZY
2Hold$4.00+0.25%Downgrades
a month ago
Apellis Pharmaceuticals IncAPLS
1Buy$52.00+198.34%Downgrades
2 months ago
Liquidia CorpLQDA
3Strong Buy$29.00+121.37%Maintains
2 months ago
Trevi Therapeutics IncTRVI
2Strong Buy$29.00+416.01%Upgrades
4 months ago
Ardelyx IncARDX
1Strong Buy$13.00+252.30%Reiterates
4 months ago
Ars Pharmaceuticals IncSPRY
3Strong Buy$28.00+53.85%Maintains
6 months ago
Omega Therapeutics IncOMGAQ
1Buy$12.00N/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.